TY - JOUR
T1 - Low- and high-grade esthesioneuroblastomas display a distinct natural history and outcome
AU - Malouf, Gabriel G.
AU - Casiraghi, Odile
AU - Deutsch, Eric
AU - Guigay, Joel
AU - Temam, Stéphane
AU - Bourhis, Jean
PY - 2013/4/1
Y1 - 2013/4/1
N2 - Purpose: Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described. Patients and methods: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009. Results: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade > III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p = 0.02), have frequent lymph node involvement (p = 0.009) and are more often unresectable (p = 0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n = 4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n = 10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively. Conclusion: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.
AB - Purpose: Esthesioneuroblastomas, also called olfactory neuroblastomas (ENB) represent a rare sinonasal neurectodermal tumour which prognostic factors are unsteadily described. Patients and methods: Clinical and pathological characteristics were analysed in patients treated at Gustave Roussy Institute between 1979 and 2009. Results: Out of 63 patients, 19 patients were reclassified and 44 patients were eligible for the analysis. Multivariate analysis revealed that T staging of the modified Dulguerov TNM staging and Hyams grade > III (that we termed high-grade ENB) were the only independent prognostic factors for overall survival (OS). As compared to patients with low-grade ENB (Hyams grade ≤ III), patients with high-grade ENB have higher T4 staging (p = 0.02), have frequent lymph node involvement (p = 0.009) and are more often unresectable (p = 0.005). Resected patients with high-grade ENB frequently displayed mainly leptomeningeal metastasis (n = 4/6) in contrast to patients with low-grade ENB who typically experience late loco-regional recurrence (n = 10/25). With a median follow-up of 9.6 years, median DFS and OS for resected low-grade ENB were 5.4 and 20.5 years, respectively. Conversely, median DFS and OS for high-grade ENB were 1.5 and 2.5 years, respectively. Conclusion: Low and high-grade ENB display distinct patterns at presentation and relapse, leading to different prognosis. Therefore, they may be regarded as distinct entities.
KW - Chemotherapy
KW - Esthesioneuroblastoma
KW - Grading
KW - Leptomeningeal metastasis
KW - ONB
KW - Olfactory neuroblastoma
KW - Outcome
KW - Surgery
UR - http://www.scopus.com/inward/record.url?scp=84875716633&partnerID=8YFLogxK
U2 - 10.1016/j.ejca.2012.12.008
DO - 10.1016/j.ejca.2012.12.008
M3 - Article
C2 - 23312882
AN - SCOPUS:84875716633
SN - 0959-8049
VL - 49
SP - 1324
EP - 1334
JO - European Journal of Cancer
JF - European Journal of Cancer
IS - 6
ER -